About Cognoa
Cognoa is a company based in Palo Alto (United States) founded in 2013 by Dennis Wall. Cognoa has raised $16.6 million across 2 funding rounds from investors including 5Y Capital. The company has 37 employees as of December 31, 2023. Cognoa offers products and services including Canvas Dx and Therapeutics Pipeline. Cognoa operates in a competitive market with competitors including DAS Health, Blueprint, Spectrum AI, Psyomics and Opeeka, among others.
- Headquarter Palo Alto, United States
- Employees 37 as on 31 Dec, 2023
- Founders Dennis Wall
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cognoa, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.6 M (USD)
in 2 rounds
-
Latest Funding Round
$11.6 M (USD), Series B
Mar 27, 2017
- Investors
-
Employee Count
37
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cognoa
Cognoa offers a comprehensive portfolio of products and services, including Canvas Dx and Therapeutics Pipeline.
AI-based tool for early autism diagnosis in children aged 1.5 to 6.
Develops interventions for developmental concerns to improve child outcomes.
People of Cognoa
Unlock access to complete
Unlock access to complete
Funding Insights of Cognoa
Cognoa has successfully raised a total of $16.6M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11.6 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cognoa
Cognoa has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include 5Y Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital firm focused on technology and innovation investments.
|
Locked | Locked | Locked |
Investor details for Cognoa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cognoa
Investment portfolio details for Cognoa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cognoa
Detailed financials for Cognoa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cognoa Comparisons
Peer comparison for Cognoa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cognoa
Cognoa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DAS Health, Blueprint, Spectrum AI, Psyomics and Opeeka, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Behavioral health assessments and IT management solutions are offered.
|
|
| Locked | Locked | Locked |
E-commerce purchases are enabled via social media messaging platforms.
|
|
| Locked | Locked | Locked |
AI-enabled behavior analysis tool for autism
|
|
| Locked | Locked | Locked |
Provider of app for mental health diagnostics in workplace and clinical trials
|
|
| Locked | Locked | Locked |
AI-based mental health assessment software is offered to doctors.
|
Detailed competitors of Cognoa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cognoa
Complete news archive for Cognoa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cognoa
Cognoa was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Cognoa is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Cognoa is a funded company, having raised a total of $16.6M across 2 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Cognoa is 37.
Founded in 2013 and based in Palo Alto, United States, Cognoa operates in the health technology sector. Digital diagnostic solutions are provided for autism in young children, addressing geographical barriers and diagnostic delays through objective, data-driven methods. Biases in assessment are mitigated, and access to timely interventions is facilitated for clinicians worldwide.
Cognoa's top competitors include Spectrum AI, Psyomics and DAS Health.
Cognoa offers Canvas Dx and Therapeutics Pipeline.
Cognoa has 1 investor. Key investors include 5Y Capital.